Uranium Energy Valuation
Is 0LJQ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0LJQ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0LJQ ($8.46) is trading above our estimate of fair value ($7.25)
Significantly Below Fair Value: 0LJQ is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0LJQ?
Key metric: As 0LJQ barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is 0LJQ's PB Ratio? | |
|---|---|
| PB Ratio | 4.5x |
| Book | US$778.11m |
| Market Cap | US$3.48b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 14851.9x |
| Enterprise Value/EBITDA | -61.4x |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does 0LJQ's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.6x | ||
YCA Yellow Cake | 0.8x | -78.1% | UK£1.2b |
HSP Hargreaves Services | 1x | 23.4% | UK£188.5m |
ENOG Energean | 3.7x | 7.0% | UK£1.9b |
ITH Ithaca Energy | 1x | -8.4% | UK£1.9b |
0LJQ Uranium Energy | 4.5x | 7.0% | US$3.5b |
Price-To-Book vs Peers: 0LJQ is expensive based on its Price-To-Book Ratio (4.5x) compared to the peer average (1.6x).
Price to Book Ratio vs Industry
How does 0LJQ's PB Ratio compare vs other companies in the GB Oil and Gas Industry?
Price-To-Book vs Industry: 0LJQ is expensive based on its Price-To-Book Ratio (4.5x) compared to the UK Oil and Gas industry average (0.8x).
Price to Book Ratio vs Fair Ratio
What is 0LJQ's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | 4.5x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate 0LJQ's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$8.46 | US$10.88 +28.6% | 9.9% | US$13.00 | US$10.00 | n/a | 6 |
| Nov ’25 | US$7.36 | US$10.61 +44.2% | 10.4% | US$13.00 | US$9.65 | n/a | 6 |
| Oct ’25 | US$6.45 | US$10.48 +62.6% | 11.2% | US$13.00 | US$9.50 | n/a | 6 |
| Sep ’25 | US$5.11 | US$10.26 +100.8% | 11.9% | US$13.00 | US$9.00 | n/a | 7 |
| Aug ’25 | US$5.16 | US$10.26 +98.8% | 11.9% | US$13.00 | US$9.00 | n/a | 7 |
| Jul ’25 | US$5.84 | US$10.26 +75.6% | 11.9% | US$13.00 | US$9.00 | n/a | 7 |
| Jun ’25 | US$7.17 | US$10.36 +44.6% | 11.2% | US$13.00 | US$9.00 | n/a | 7 |
| May ’25 | US$6.84 | US$10.36 +51.6% | 11.2% | US$13.00 | US$9.00 | n/a | 7 |
| Apr ’25 | US$6.85 | US$10.33 +50.8% | 11.2% | US$13.00 | US$9.00 | n/a | 7 |
| Mar ’25 | US$7.05 | US$10.33 +46.5% | 11.4% | US$13.00 | US$9.00 | n/a | 7 |
| Feb ’25 | US$8.28 | US$9.68 +16.9% | 19.9% | US$13.00 | US$6.60 | n/a | 6 |
| Jan ’25 | US$6.48 | US$7.31 +12.9% | 10.2% | US$8.50 | US$6.50 | n/a | 7 |
| Dec ’24 | US$6.62 | US$6.99 +5.5% | 7.8% | US$8.25 | US$6.50 | n/a | 7 |
| Nov ’24 | US$5.81 | US$6.95 +19.6% | 6.6% | US$8.00 | US$6.50 | US$7.36 | 7 |
| Oct ’24 | US$5.24 | US$6.70 +27.9% | 9.5% | US$8.00 | US$6.00 | US$6.45 | 7 |
| Sep ’24 | US$4.42 | US$6.82 +54.3% | 9.0% | US$8.00 | US$6.00 | US$5.11 | 6 |
| Aug ’24 | US$3.56 | US$6.82 +91.5% | 9.0% | US$8.00 | US$6.00 | US$5.16 | 6 |
| Jul ’24 | US$3.38 | US$6.85 +102.7% | 9.0% | US$8.00 | US$6.00 | US$5.84 | 6 |
| Jun ’24 | US$2.92 | US$6.85 +134.6% | 9.0% | US$8.00 | US$6.00 | US$7.17 | 6 |
| May ’24 | US$2.60 | US$6.85 +163.5% | 11.0% | US$8.25 | US$5.75 | US$6.84 | 6 |
| Apr ’24 | US$2.91 | US$6.85 +135.4% | 11.0% | US$8.25 | US$5.75 | US$6.85 | 6 |
| Mar ’24 | US$3.72 | US$6.89 +85.2% | 10.1% | US$8.25 | US$6.00 | US$7.05 | 6 |
| Feb ’24 | US$3.92 | US$6.89 +75.8% | 10.1% | US$8.25 | US$6.00 | US$8.28 | 6 |
| Jan ’24 | US$3.82 | US$6.87 +79.7% | 11.1% | US$8.25 | US$6.00 | US$6.48 | 5 |
| Dec ’23 | US$3.73 | US$6.92 +85.6% | 10.2% | US$8.25 | US$6.25 | US$6.62 | 5 |
| Nov ’23 | US$4.17 | US$6.92 +65.9% | 10.2% | US$8.25 | US$6.25 | US$5.81 | 5 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
Avance Gas Holding
NOK 8.1b
Engages in the transportation of liquefied petroleum gas (LPG) worldwide.
0QTX
NOK 104.60
7D
-1.5%
1Y
-40.8%
TotalEnergies
€130.2b
A multi-energy company, produces and markets oil and biofuels, natural gas, green gases, renewables, and electricity in France, rest of Europe, North America, Africa, and internationally.
TTE
€59.70
7D
2.1%
1Y
-7.0%
VAALCO Energy
US$561.3m
An independent energy company, engages in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids in Gabon, Egypt, Equatorial Guinea, and Canada.
EGY
US$4.63
7D
0%
1Y
28.5%